Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1975 Sep;28(9):722–727. doi: 10.1136/jcp.28.9.722

Effect of human lysozyme (muramidase) on potassium handling by the perfused rat kidney. A mechanism for renal damage in human monocytic leukaemia.

D Y Mason, D T Howes, C R Taylor, B D Ross
PMCID: PMC475814  PMID: 1058211

Abstract

Purified human lysozyme (muramidase) stimulated potassium excretion by the isolated perfused rat kidney. Lysozyme is filtered and reabsorbed, without a tubular maximum. Over 90% of lysozyme filtered is retained within the kidney; 50% was recovered by enzymic assay and histologically localized to the proximal tubular cells. Hypokalaemia seen in some patients with myelomonocytic leukaemia may be directly attributed to an elevated circulating lysozyme level.

Full text

PDF
724

Images in this article

724Image
on p.724
725Image
on p.725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balazs T., Roepke R. R. Lysozymuria induced in rats by nephrotoxic agents. Proc Soc Exp Biol Med. 1966 Nov;123(2):380–385. doi: 10.3181/00379727-123-31494. [DOI] [PubMed] [Google Scholar]
  2. DICKERMAN H. W., WALKER W. G. EFFECT OF CATIONIC AMINO ACID INFUSION ON POTASSIUM METABOLISM IN VIVO. Am J Physiol. 1964 Feb;206:403–408. doi: 10.1152/ajplegacy.1964.206.2.403. [DOI] [PubMed] [Google Scholar]
  3. Giebisch G., Klose R. M., Malnic G. Renal tubular potassium transport. Bull Schweiz Akad Med Wiss. 1967 Dec;23(3):287–312. [PubMed] [Google Scholar]
  4. Glynn A. A. Lysozyme: antigen, enzyme and antibacterial agent. Sci Basis Med Annu Rev. 1968:31–52. [PubMed] [Google Scholar]
  5. Hansen N. E., Karle H., Andersen V., Olgaard K. Lysozyme turnover in man. J Clin Invest. 1972 May;51(5):1146–1155. doi: 10.1172/JCI106907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Johansson B. G., Malmquist J. Quantitative immunochemical determination of lysoqyme (muramidase) in serum and urine. Scand J Clin Lab Invest. 1971 May;27(3):255–261. doi: 10.3109/00365517109080216. [DOI] [PubMed] [Google Scholar]
  7. Mason D. Y., Taylor C. R. The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol. 1975 Feb;28(2):124–132. doi: 10.1136/jcp.28.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Muggia F. M., Heinemann H. O., Farhangi M., Osserman E. F. Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Am J Med. 1969 Sep;47(3):351–366. doi: 10.1016/0002-9343(69)90219-8. [DOI] [PubMed] [Google Scholar]
  9. Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966 Nov 1;124(5):921–952. doi: 10.1084/jem.124.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pickering T. G., Catovsky D. Hypokalaemia and raised lysozyme levels in acute myeloid leukaemia. Q J Med. 1973 Oct;42(168):677–682. [PubMed] [Google Scholar]
  11. Ross B. D., Epstein F. H., Leaf A. Sodium reabsorption in the perfused rat kidney. Am J Physiol. 1973 Nov;225(5):1165–1171. doi: 10.1152/ajplegacy.1973.225.5.1165. [DOI] [PubMed] [Google Scholar]
  12. Wiernik P. H., Serpick A. A. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Am J Med. 1969 Mar;46(3):330–343. doi: 10.1016/0002-9343(69)90036-9. [DOI] [PubMed] [Google Scholar]
  13. Zucker S., Hanes D. J., Vogler W. R., Eanes R. Z. Plasma muramidase: a study of methods and clinical applications. J Lab Clin Med. 1970 Jan;75(1):83–92. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES